EMA’s New Emergency Task Force Gets ‘Balanced’ COVID-19 Expertise
Executive Summary
The task force, which is a key component of the European Medicines Agency’s extended mandate, will include experts in the fields of vaccinology, antivirals, clinical trials, immunology and immunotherapy.
You may also be interested in...
New EU Body To Deal With COVID-19 Vaccine Strategy & Procurement
Europe is stepping up its efforts to prepare for future health crises. A new parliamentary committee will look at how to make the most of the lessons learned from the coronavirus pandemic, while EU health ministers will next week discuss “vaccine solidarity” and the draft regulation on cross-border threats to health.
New EMA Chair Pledges Agility, Responsiveness & Solidarity In Turbulent Times
Lorraine Nolan has become the new chair of the European Medicines Agency’s management board.
EMA Takes Over Permanent Secretariat For Medical Device And IVD Expert Panels
Despite resistance from the medtech industry, the European Medicines Agency now has a key role in the medical device and IVD expert panels, which have only recently been set up.